$CLRO
CLEARONE INC Stock $clro

$clro Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000175392624000998 Filed on May 17, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$2.304M	$3.622M	$4.154M
YoY Change	-57.98%	-13.31%	3.31%
Cost Of Revenue	$2.324M	$2.471M	$2.576M
YoY Change	-36.07%	-13.69%	-6.57%
Gross Profit	-$20.00K	$1.151M	$1.578M
YoY Change	-101.08%	-12.47%	24.84%
Gross Profit Margin	-0.87%	31.78%	37.99%
Selling, General & Admin	$2.036M	$2.335M	$2.451M
YoY Change	-12.62%	-5.12%	-14.6%
% of Gross Profit		202.87%	155.32%
Research & Development	$868.0K	$894.0K	$866.0K
YoY Change	-0.57%	-14.29%	-11.99%
% of Gross Profit		77.67%	54.88%
Depreciation & Amortization	$106.0K	$167.0K	$231.0K
YoY Change	-53.51%	-24.43%	-60.17%
% of Gross Profit		14.51%	14.64%
Operating Expenses	$2.904M	$3.229M	$3.317M
YoY Change	-9.33%	-7.85%	-13.93%
Operating Profit	-$2.924M	-$2.078M	-$1.739M
YoY Change	115.79%	-5.07%	-32.86%
Interest Expense	$0.00	$0.00	-$68.00K
YoY Change	-100.0%	-100.0%	-49.63%
% of Operating Profit
Other Income/Expense, Net	$119.0K	$178.0K	$1.037M
YoY Change	-72.77%	-89.32%	-96.91%
Pretax Income	-$2.805M	-$1.900M	$3.030M
YoY Change	178.0%	133.13%	-90.19%
Income Tax	$15.00K	-$2.000K	$388.0K
% Of Pretax Income			12.81%
Net Earnings	-$2.820M	-$1.898M	$2.642M
YoY Change	176.74%	128.13%	-89.0%
Net Earnings / Revenue	-122.4%	-52.4%	63.6%
Basic Earnings Per Share	-$0.12	-$0.08
Diluted Earnings Per Share	-$0.12	-$0.08	$0.11
COMMON SHARES
Basic Shares Outstanding	23.97M shares	23.97M shares	23.96M shares
Diluted Shares Outstanding	23.97M shares	23.97M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.923M	$22.63M	$21.32M
YoY Change	-77.1%	-61.65%	2066.16%
Cash & Equivalents	$2.450M	$18.54M	$17.84M
Short-Term Investments	$2.473M	$4.087M	$3.480M
Other Short-Term Assets	$3.855M	$4.001M	$4.062M
YoY Change	-9.78%	10.07%	-47.98%
Inventory	$14.60M	$11.43M	$10.63M
Prepaid Expenses
Receivables	$2.574M	$2.794M	$3.279M
Other Receivables	$27.00K	$27.00K	$4.036M
Total Short-Term Assets	$25.36M	$39.61M	$43.32M
YoY Change	-42.27%	-46.89%	-44.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$552.0K	$542.0K	$1.520M
YoY Change	-69.08%	52.25%	296.87%
Goodwill
YoY Change
Intangibles	$1.582M	$1.615M	$1.689M
YoY Change	-16.87%	-19.05%	-18.45%
Long-Term Investments	$621.0K	$1.278M	$916.0K
YoY Change	5.97%
Other Assets	$108.0K	$108.0K	$3.252M
YoY Change	-96.89%	-3.57%	2727.83%
Total Long-Term Assets	$5.439M	$8.602M	$7.377M
YoY Change	-29.81%	30.2%	16.67%
TOTAL ASSETS
Total Short-Term Assets	$25.36M	$39.61M	$43.32M
Total Long-Term Assets	$5.439M	$8.602M	$7.377M
Total Assets	$30.80M	$48.21M	$50.69M
YoY Change	-40.41%	-40.62%	-39.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.901M	$1.733M	$1.945M
YoY Change	-21.93%	-4.78%	51.48%
Accrued Expenses	$1.726M	$1.959M	$2.290M
YoY Change	-33.28%	-20.17%	-24.7%
Deferred Revenue	$23.00K	$26.00K	$30.00K
YoY Change	-55.77%	-63.38%	-52.38%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$3.650M	$18.21M	$4.265M
YoY Change	-43.45%	208.66%	-47.48%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.079M	$1.079M	$1.744M
YoY Change	-41.86%	7.04%	73.02%
Total Long-Term Liabilities	$1.079M	$1.079M	$1.744M
YoY Change	-41.86%	7.04%	73.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.650M	$18.21M	$4.265M
Total Long-Term Liabilities	$1.079M	$1.079M	$1.744M
Total Liabilities	$5.244M	$19.87M	$6.009M
YoY Change	-36.9%	152.83%	-37.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.794M	-$2.974M	-$1.076M
YoY Change	144.78%	120.62%	108.53%
Common Stock	$31.64M	$31.61M	$46.07M
YoY Change	-31.22%	-57.83%	-38.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$25.55M	$28.34M	$44.69M
YoY Change
Total Liabilities & Shareholders Equity	$30.80M	$48.21M	$50.69M
YoY Change	-40.41%	-40.62%	-39.47%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$2.820M	-$1.898M	$2.642M
YoY Change	176.74%	128.13%	-89.0%
Depreciation, Depletion And Amortization	$106.0K	$167.0K	$231.0K
YoY Change	-53.51%	-24.43%	-60.17%
Cash From Operating Activities	-$3.155M	$433.0K	$3.488M
YoY Change	-57.37%	-99.28%	-264.61%
INVESTING ACTIVITIES
Capital Expenditures	$83.00K	$69.00K	$30.00K
YoY Change	-75.3%	155.56%	-61.54%
Acquisitions
YoY Change
Other Investing Activities	$1.636M	$378.0K	$1.927M
YoY Change	-123.41%		-2172.04%
Cash From Investing Activities	$1.553M	$273.0K	$1.897M
YoY Change	-121.2%	-495.65%	-1209.36%
FINANCING ACTIVITIES
Cash Dividend Paid	$14.49M
YoY Change	-50.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-14.49M	$7.000K	-1.242M
YoY Change	-50.38%	-100.31%	-168.24%
NET CHANGE
Cash From Operating Activities	-3.155M	$433.0K	3.488M
Cash From Investing Activities	1.553M	$273.0K	1.897M
Cash From Financing Activities	-14.49M	$7.000K	-1.242M
Net Change In Cash	-16.09M	$709.0K	4.143M
YoY Change	-63.37%	-98.78%	-981.49%
FREE CASH FLOW
Cash From Operating Activities	-$3.155M	$433.0K	$3.488M
Capital Expenditures	$83.00K	$69.00K	$30.00K
Free Cash Flow	-$3.238M	$364.0K	$3.458M
YoY Change	-58.15%	-99.4%	-257.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	5000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2471000	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23969148	shares
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000840715
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	CLEARONE INC
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-33660
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0398877
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5225 Wiley Post Way, Suite 500
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84116
CY2024Q1	dei	City Area Code CityAreaCode	(801)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	975-7200
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001
CY2024Q1	dei	Trading Symbol TradingSymbol	CLRO
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23969148	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18544000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17835000	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2809000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	3480000	usd
CY2024Q1	clro	Receivables Legal Settlement ReceivablesLegalSettlement	0	usd
CY2023Q4	clro	Receivables Legal Settlement ReceivablesLegalSettlement	4000000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	326000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	326000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2794000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3279000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	11434000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	10625000	usd
CY2024Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	27000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	36000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4001000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4062000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	43317000	usd
CY2024Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1278000	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	916000	usd
CY2024Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	4161000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	3143000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1269000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	530000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	898000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	990000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1615000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1689000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	108000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	109000	usd
CY2024Q1	us-gaap	Assets Assets	48211000	usd
CY2023Q4	us-gaap	Assets Assets	50694000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1733000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1945000	usd
CY2024Q1	us-gaap	Interest And Dividends Payable Current InterestAndDividendsPayableCurrent	14496000	usd
CY2023Q4	us-gaap	Interest And Dividends Payable Current InterestAndDividendsPayableCurrent	0	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1959000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2290000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	26000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	30000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	18214000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4265000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	574000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	665000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1079000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1079000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	19867000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	6009000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23969148	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23969148	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23969148	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	24000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	24000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	31584000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	46047000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-290000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-310000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2974000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1076000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	28344000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	44685000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48211000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50694000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3622000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2863000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	1151000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1315000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1312000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1192000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	894000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1043000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1023000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3229000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3504000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2078000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2189000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	0	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	292000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	178000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1666000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1900000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-815000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1898000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-832000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23969148	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23955767	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23969148	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23955767	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-832000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	22000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1878000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-827000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1898000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-832000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	167000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	221000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	92000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	129000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	26000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	23000	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	193000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	23000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	47000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	8000	usd
CY2024Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-4485000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-62000	usd
CY2024Q1	clro	Increase Decrease In Legal Settlement Receivables IncreaseDecreaseInLegalSettlementReceivables	0	usd
CY2023Q1	clro	Increase Decrease In Legal Settlement Receivables IncreaseDecreaseInLegalSettlementReceivables	-55000000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2020000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-365000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-61000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4176000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-211000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	536000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-321000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-551000	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	9000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	1293000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-4000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	8000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-99000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-124000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	433000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	60321000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	69000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27000	usd
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	36000	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	42000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2325000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1947000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	273000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-69000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	7000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	usd
CY2024Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	2225000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2225000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	709000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	58031000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17835000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	986000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18544000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59017000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-12000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	18000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	231000	usd
CY2024Q1	clro	Dividends Payable DividendsPayable	14496000	usd
CY2023Q1	clro	Dividends Payable DividendsPayable	0	usd
CY2024Q1	clro	Available For Sale Marketable Securities Accumulated Gross Unrealized Gain AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedGain	9000	usd
CY2024Q1	clro	Available For Sale Marketable Securities Accumulated Gross Unrealized Loss AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedLoss	2000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18544000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17835000	usd
CY2024Q1	clro	Working Capital Deficit WorkingCapitalDeficit	21395000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	433000	usd
CY2024Q1	clro	Increase Decrease In Net Cash Provided By Used In Operating Activities IncreaseDecreaseInNetCashProvidedByUsedInOperatingActivities	59888000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	60321000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3622000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4178000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3622000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4178000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1898000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-832000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23969148	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23955767	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23969148	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23955767	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2024Q1	clro	Incremental Common Shares Attributable To Dilutive Effect Of Weighted Average Options Warrants And Convertible Portion Of Senior Convertible Notes Outstanding IncrementalCommonSharesAttributableToDilutiveEffectOfWeightedAverageOptionsWarrantsAndConvertiblePortionOfSeniorConvertibleNotesOutstanding	6420553	shares
CY2023Q1	clro	Incremental Common Shares Attributable To Dilutive Effect Of Weighted Average Options Warrants And Convertible Portion Of Senior Convertible Notes Outstanding IncrementalCommonSharesAttributableToDilutiveEffectOfWeightedAverageOptionsWarrantsAndConvertiblePortionOfSeniorConvertibleNotesOutstanding	6368420	shares
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6420553	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6368420	shares
CY2024Q1	clro	Available For Sale Marketable Securities Amortized Cost AvailableForSaleMarketableSecuritiesAmortizedCost	4080000	usd
CY2024Q1	us-gaap	Marketable Securities MarketableSecurities	4087000	usd
CY2023Q4	clro	Available For Sale Marketable Securities Amortized Cost AvailableForSaleMarketableSecuritiesAmortizedCost	4412000	usd
CY2023Q4	clro	Available For Sale Marketable Securities Accumulated Gross Unrealized Gain AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedGain	7000	usd
CY2023Q4	clro	Available For Sale Marketable Securities Accumulated Gross Unrealized Loss AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedLoss	23000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	4396000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2801000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2809000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1279000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1278000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	0	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	0	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	4080000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4087000	usd
CY2024Q1	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Fair Value MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairValue	4087000	usd
CY2024Q1	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	-2000	usd
CY2024Q1	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Fair Value MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairValue	0	usd
CY2024Q1	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2024Q1	clro	Marketable Securities Available For Sale Unrealized Loss Position Fair Value MarketableSecuritiesAvailableForSaleUnrealizedLossPositionFairValue	4087000	usd
CY2024Q1	clro	Marketable Securities Available For Sale Unrealized Loss Position Accumulated Loss MarketableSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	-2000	usd
CY2023Q4	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Fair Value MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairValue	4396000	usd
CY2023Q4	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	-23000	usd
CY2023Q4	clro	Marketable Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2023Q4	clro	Marketable Securities Available For Sale Unrealized Loss Position Fair Value MarketableSecuritiesAvailableForSaleUnrealizedLossPositionFairValue	4396000	usd
CY2023Q4	clro	Marketable Securities Available For Sale Unrealized Loss Position Accumulated Loss MarketableSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	-23000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11083000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11047000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9468000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9358000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1615000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1689000	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	193000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	110000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	118000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	147000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	196000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	195000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	65000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	21000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	991000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1615000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1765000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2086000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9669000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8539000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	11434000	usd
CY2024Q1	clro	Inventory Noncurrent Raw Materials Net Of Reserves InventoryNoncurrentRawMaterialsNetOfReserves	2259000	usd
CY2023Q4	clro	Inventory Noncurrent Raw Materials Net Of Reserves InventoryNoncurrentRawMaterialsNetOfReserves	1789000	usd
CY2024Q1	clro	Inventory Noncurrent Finished Goods Net Of Reserves InventoryNoncurrentFinishedGoodsNetOfReserves	1902000	usd
CY2023Q4	clro	Inventory Noncurrent Finished Goods Net Of Reserves InventoryNoncurrentFinishedGoodsNetOfReserves	1354000	usd
CY2024Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	4161000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	3143000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	23000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	109000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	149000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	115000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	151000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	758000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	898000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	990000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	375000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	383000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	574000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	665000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	949000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1048000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y3M
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M20D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0652	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0647	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	324000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	272000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	211000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	216000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	36000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1059000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	110000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	949000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	28344000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	73326000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	160000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0391	pure
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9147	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	607810	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.03
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	20000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	587810	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.16
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	416898	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.76
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	120000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y2M26D
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	968000	usd
CY2024Q1	us-gaap	Marketable Securities MarketableSecurities	4087000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	4396000	usd
CY2024Q1	us-gaap	Dividends Dividends	14496000	usd

Files In Submission

Name	View Source	Status
clro-20240331_cal.xml	Edgar Link	unprocessable
0001753926-24-000998-index-headers.html	Edgar Link	pending
0001753926-24-000998-index.html	Edgar Link	pending
0001753926-24-000998.txt	Edgar Link	pending
0001753926-24-000998-xbrl.zip	Edgar Link	pending
clro-20240331.htm	Edgar Link	pending
clro-20240331.xsd	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
clro-20240331_def.xml	Edgar Link	unprocessable
clro-20240331_lab.xml	Edgar Link	unprocessable
clro-20240331_pre.xml	Edgar Link	unprocessable
clro-20240331_htm.xml	Edgar Link	completed
ex312_2.htm	Edgar Link	pending
ex321_3.htm	Edgar Link	pending
ex322_4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLRO
CLEARONE INC Stock $clro

2024 Q2 Form 10-Q Financial Statement

#000175392624000998 Filed on May 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRO CLEARONE INC Stock $clro

2024 Q2 Form 10-Q Financial Statement

#000175392624000998 Filed on May 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRO
CLEARONE INC Stock $clro